Search results
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 1 month agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 1 month agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Patients seek relief from spiraling drug prices. Will the Inflation Reduction Act deliver?
USA TODAY via Yahoo News· 2 years agoJackie Trapp has incurable blood cancer and takes a chemotherapy drug that cost more than $240,000...
Patients with incurable cervical cancer to be offered life-extending drug
The Independent UK via AOL· 1 year agoPatients with incurable cervical cancer are to be offered a new treatment which could give them more...
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration
Barrons.com· 2 months agoMerck secured Food and Drug Administration approval for a drug widely expected to be an era-defining...
New drug for cervical cancer patients approved for use in NHS in Scotland
Press Association News via AOL· 1 year agoScotland has become the the first part of the UK to make a new treatment for women with advanced...
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
Investor's Business Daily· 5 months agoMerck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the...
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Reuters via Yahoo News· 1 year agoMerck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...
5 FDA decisions to watch in the first quarter
BioPharma Dive via Yahoo Finance· 5 months agoBiotechnology is often described as an “innovation” industry, dependent on companies’ ability to invent and develop new medicines. By that metric, 2023...
Personalized cancer vaccine results are a 'home run': Moderna CEO
Yahoo Finance via AOL· 1 year agoPreliminary results from a personalized cancer vaccine jointly studied by Moderna (MRNA) and Merck...